Скачать или смотреть BioInnovation Greece 2025 Forum - Greece 2035: A Vision for Global Leadership in Biotechnology

BioInnovation Greece 2025 Forum, Day 1, Session 7 - Roundtable Panel Discussion: Greece 2035: A Vision for Global Leadership in Biotechnology
Moderator: Fay Christodoulou, Chief Scientific Officer, Microfluidics, INTEGRA Biosciences, USA
Panelists: Spyros Artavanis Tsakonas, Professor Emeritus, Harvard University, USA; Stelios Papadopoulos, Chairman, Exelixis Inc., USA; Simos Simeonidis, Co-Founder and Managing Partner, Kos Biotechnology Partners, Greece; Kleanthis Xanthopoulos, Chairman & CEO at Shoreline Biosciences, Inc. USA

Panel Conclusions
The panel underscored that Greece’s biotech ascent will come from realism, focus, and collaboration: long-horizon drug R&D demands a culture that normalizes failure, relies on seasoned judgment for when to pivot or stop, and is rooted in strong basic science within universities. Capital will follow quality—not nationality—so Greece should choose a few lanes, excel in them (initially pharma/biotech services and data/AI capabilities), and deliberately leverage the diaspora through hybrid models (R&D in Greece; BD/clinical/commercial in US/EU). With smart, professional governance (not bureaucratic fiefdoms), coordinated research–education policy, and strategic opportunism amid global shifts (including China’s rise), a handful of viable companies can set foundations for sustained impact by 2035.
Full Program: https://bio3-2025.bioinnovation.gr/pr...